Concepedia

Author

Y. Liu

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Y. Liu, Yang Liu

6

Publications

96

Citations

5

H-Index

13

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)University of Utah
YL

About

Y. Liu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in natural sciences, biochemistry, and analytical chemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

14

2

Natural Sciences

1

1

54

3

Biochemistry

1

1

54

4

Chemistry

1

1

54

5

Immunology

1

1

14

Y. Liu

×

4

Publications

90

Citations

4

H-Index

YearCitations

Evaluation of a C18 hybrid stationary phase using high-temperature chromatography

Y. Liu, Nelu Grinberg, Karen Thompson,

Analytica Chimica Acta

2005

54

LBA69 Belzutifan, a HIF-2α Inhibitor, for von Hippel-Lindau (VHL) disease-associated neoplasms: 36 months of follow-up of the phase II LITESPARK-004 study

Ramaprasad Srinivasan, Othon Iliopoulos, W. Kimryn Rathmell,

Annals of Oncology

2022

14

1772MO Pembrolizumab (pembro) plus enzalutamide (enza) and androgen deprivation therapy (ADT) for patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC): Randomized double-blind phase III KEYNOTE-991 study

Christian Gratzke, Mustafa Özgüroğlu, A. Peer,

Annals of Oncology

2023

11

Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma

Neeraj Agarwal, James Brugarolas, Pooja Ghatalia,

Annals of Oncology

2024

11

Page 1